Literature DB >> 976935

Purification and characterization of a protein from porcine gut with glucagon-like immunoreactivity.

F Sundby, H Jacobsen, A J Moody.   

Abstract

A protein with glucagon-like immunoreactivity has been isolated from porcine intestine in a highly purified form. The isoelectric point is 6.8-6.9, and the molecular weight is 11,625, as calculated from its amino acid composition: this estimate has been confirmed by S.D.S. gel electrophoresis. The partial sequence so far elucidated is from the N-terminal: Arg-Ser-Leu-Gin-Asn-Thr-Glx-Glx-Lys-Ala-Arg-Ser-Phe-, and from the C-terminal: -Ile-Ala, both differing from those of porcine pancreatic glucagon. On a molar basis the protein has the same immunoreactivity as porcine glucagon when assayed with some anti-glucagon sera, while the activity is less than 0.2% using other anti-glucagon sera.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 976935     DOI: 10.1055/s-0028-1093615

Source DB:  PubMed          Journal:  Horm Metab Res        ISSN: 0018-5043            Impact factor:   2.936


  26 in total

Review 1.  Glucagon-like peptide 1 (GLP-1).

Authors:  T D Müller; B Finan; S R Bloom; D D'Alessio; D J Drucker; P R Flatt; A Fritsche; F Gribble; H J Grill; J F Habener; J J Holst; W Langhans; J J Meier; M A Nauck; D Perez-Tilve; A Pocai; F Reimann; D A Sandoval; T W Schwartz; R J Seeley; K Stemmer; M Tang-Christensen; S C Woods; R D DiMarchi; M H Tschöp
Journal:  Mol Metab       Date:  2019-09-30       Impact factor: 7.422

2.  Gut glucagon-like immunoreactants (GLIs) and other enteric glucagon-like peptides.

Authors:  A J Moody
Journal:  J Clin Pathol Suppl (Assoc Clin Pathol)       Date:  1978

Review 3.  Multiple forms of gastroenteropancreatic hormones.

Authors:  G B Irvine; R F Murphy
Journal:  Gut       Date:  1981-12       Impact factor: 23.059

4.  Trophic effects of glicentin on rat small-intestinal mucosa in vivo and in vitro.

Authors:  S Myojo; T Tsujikawa; M Sasaki; Y Fujiyama; T Bamba
Journal:  J Gastroenterol       Date:  1997-06       Impact factor: 7.527

5.  Conversion of proglucagon in pancreatic alpha cells: the major endproducts are glucagon and a single peptide, the major proglucagon fragment, that contains two glucagon-like sequences.

Authors:  C Patzelt; E Schiltz
Journal:  Proc Natl Acad Sci U S A       Date:  1984-08       Impact factor: 11.205

6.  The glucagon-like polypeptides - order out of chaos?

Authors:  J M Conlon
Journal:  Diabetologia       Date:  1980       Impact factor: 10.122

7.  Peptide YY (PYY) immunoreactivity is co-stored with glucagon-related immunoreactants in endocrine cells of the gut and pancreas.

Authors:  A Ali-Rachedi; I M Varndell; T E Adrian; D A Gapp; S Van Noorden; S R Bloom; J M Polak
Journal:  Histochemistry       Date:  1984

8.  Glicentin-containing cells in intestinal metaplasia, adenoma and carcinoma of the stomach.

Authors:  H Ito; H Yokozaki; J Hata; K Mandai; E Tahara
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1984

9.  Extrapancreatic glucagon and glucagonlike immunoreactivity in depancreatized dogs. A quantitative assessment of secretion rates and anatomical delineation of sources.

Authors:  W A Muller; L Girardier; J Seydoux; M Berger; A E Renold; M Vranic
Journal:  J Clin Invest       Date:  1978-07       Impact factor: 14.808

10.  The response of gastric inhibitory polypeptide (GIP) and insulin to glucose in duodenal ulcer patients.

Authors:  K B Lauritsen; A J Moody
Journal:  Diabetologia       Date:  1978-03       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.